公开(公告)号：US20240158851A1

公开(公告)日：2024-05-16

申请号：US18420013

申请日：2024-01-23

Applicant: KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY

Inventor： Heh-In IM ,  Baek Sun KIM ,  Sung Hyun TAG

IPC: C12Q1/6876

CPC classification number: C12Q1/6876 ,  C12Q1/686 ,  C12Q2600/178

Abstract: Disclosed is a composition for diagnosing, preventing or treating drug addiction based on synaptotagmin binding cytoplasmic RNA interacting protein (SYNCRIP). SYNCRIP or a gene encoding the protein can be used to diagnose drug addiction. In addition, a therapeutic agent for drug addiction can be discovered by measuring the expression of SYNCRIP. Furthermore, an agent expressing SYNCRIP or promoting the activity of SYNCRIP can be used to prevent or treat drug addiction.

公开(公告)号：US20210403996A1

公开(公告)日：2021-12-30

申请号：US17334345

申请日：2021-05-28

Applicant: KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY

Inventor： Heh-In IM ,  Byung Sun KIM ,  Sung Hyun TAG

IPC: C12Q1/6876

Abstract: Disclosed is a composition for diagnosing, preventing or treating drug addiction based on synaptotagmin binding cytoplasmic RNA interacting protein (SYNCRIP). SYNCRIP or a gene encoding the protein can be used to diagnose drug addiction. In addition, a therapeutic agent for drug addiction can be discovered by measuring the expression of SYNCRIP. Furthermore, an agent expressing SYNCRIP or promoting the activity of SYNCRIP can be used to prevent or treat drug addiction.